September 01, 2015 Archives - Clinical Advisor

Print Issue: September 01, 2015

Naloxegol is an antagonist of opioid binding at the mu-opioid receptor.

PAMORA for opioid-induced constipation

Naloxegol functions as a peripherally acting mu-opioid receptor antagonist in tissues such as the gastrointestinal tract, thereby decreasing the constipating effects of opioids.

Next post in Clinical Pearls